comparemela.com

Latest Breaking News On - National list of essential medicines - Page 8 : comparemela.com

Strong performance in US market to support growth of Indian pharma industry in FY24: ICRA

Strong performance in US market to support growth of Indian pharma industry in FY24: ICRA
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

FY24 India growth projection: Pharma Sector: ICRA expects 9-11% growth in FY24 led by new launches, US rebound

Credit rating agency ICRA predicts that the revenues of 25 Indian pharmaceutical companies, which account for 60% of the Indian pharmaceutical industry s total revenues, will expand by 9-11% in FY24, compared to 10% in the previous year. The operating profit margin (OPM) is projected to improve to 22-23% in FY24, compared to 20.7% in FY2023.

Strong performance in US market to support Indian pharma industry growth in FY24

Strong performance in US market to support Indian pharma industry growth in FY24
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

FY24 India growth projection: Pharma Sector: ICRA expects 9-11% growth in FY24 led by new launches, US rebound

Credit rating agency ICRA predicts that the revenues of 25 Indian pharmaceutical companies, which account for 60% of the Indian pharmaceutical industry s total revenues, will expand by 9-11% in FY24, compared to 10% in the previous year. The operating profit margin (OPM) is projected to improve to 22-23% in FY24, compared to 20.7% in FY2023.

NGSO to widen GAS access for gold card holders

NGSO to widen GAS access for gold card holders
bangkokpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bangkokpost.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.